0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Febrile Neonates

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in pediatric patients are mild or asymptomatic. However, infants have emerged at higher risk of hospitalization and severe outcomes in pediatric coronavirus disease 2019 (COVID-19). We report a case series of 4 full-term neonates hospitalized with fever and found to have SARS-CoV-2 infection with a spectrum of illness severities. Two neonates required admission to the intensive care unit for respiratory insufficiency and end organ involvement. Half of the patients were found to have a coinfection. One neonate received antiviral therapy with remdesivir and is, to our knowledge, the youngest patient to receive this drug for COVID-19. All neonates had favorable outcomes.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China

          To identify the epidemiological characteristics and transmission patterns of pediatric patients with the 2019 novel coronavirus disease (COVID-19) in China.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            SARS-CoV-2 Infection in Children

            To the Editor: As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and clinical features of infected children are limited. 1-3 A recent review of 72,314 cases by the Chinese Center for Disease Control and Prevention showed that less than 1% of the cases were in children younger than 10 years of age. 2 In order to determine the spectrum of disease in children, we evaluated children infected with SARS-CoV-2 and treated at the Wuhan Children’s Hospital, the only center assigned by the central government for treating infected children under 16 years of age in Wuhan. Both symptomatic and asymptomatic children with known contact with persons having confirmed or suspected SARS-CoV-2 infection were evaluated. Nasopharyngeal or throat swabs were obtained for detection of SARS-CoV-2 RNA by established methods. 4 The clinical outcomes were monitored up to March 8, 2020. Of the 1391 children assessed and tested from January 28 through February 26, 2020, a total of 171 (12.3%) were confirmed to have SARS-CoV-2 infection. Demographic data and clinical features are summarized in Table 1. (Details of the laboratory and radiologic findings are provided in the Supplementary Appendix, available with the full text of this letter at NEJM.org.) The median age of the infected children was 6.7 years. Fever was present in 41.5% of the children at any time during the illness. Other common signs and symptoms included cough and pharyngeal erythema. A total of 27 patients (15.8%) did not have any symptoms of infection or radiologic features of pneumonia. A total of 12 patients had radiologic features of pneumonia but did not have any symptoms of infection. During the course of hospitalization, 3 patients required intensive care support and invasive mechanical ventilation; all had coexisting conditions (hydronephrosis, leukemia [for which the patient was receiving maintenance chemotherapy], and intussusception). Lymphopenia (lymphocyte count, <1.2×109 per liter) was present in 6 patients (3.5%). The most common radiologic finding was bilateral ground-glass opacity (32.7%). As of March 8, 2020, there was one death. A 10-month-old child with intussusception had multiorgan failure and died 4 weeks after admission. A total of 21 patients were in stable condition in the general wards, and 149 have been discharged from the hospital. This report describes a spectrum of illness from SARS-CoV-2 infection in children. In contrast with infected adults, most infected children appear to have a milder clinical course. Asymptomatic infections were not uncommon. 2 Determination of the transmission potential of these asymptomatic patients is important for guiding the development of measures to control the ongoing pandemic.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              COVID-19 and African Americans

                Bookmark

                Author and article information

                Journal
                J Pediatric Infect Dis Soc
                J Pediatric Infect Dis Soc
                jpids
                Journal of the Pediatric Infectious Diseases Society
                Oxford University Press (US )
                2048-7193
                2048-7207
                09 July 2020
                : piaa084
                Affiliations
                [1 ] Division of Infectious Diseases, Department of Pediatrics, Boston Children’s Hospital , Boston, Massachusetts, USA
                [2 ] Harvard Medical School , Boston, Massachusetts, USA
                [3 ] Department of Cardiology, Boston Children’s Hospital , Boston, Massachusetts, USA
                Author notes
                Correspondence: Hanna Wardell, MD, Division of Infectious Disease, Department of Pediatrics, Boston Children’s Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail: hanna.wardell@ 123456childrens.harvard.edu .
                Author information
                http://orcid.org/0000-0002-6538-6085
                http://orcid.org/0000-0001-7230-6285
                http://orcid.org/0000-0002-8381-3298
                Article
                piaa084
                10.1093/jpids/piaa084
                7454701
                32645175
                83371b02-8eaf-4b64-9839-0a64d5762e8b
                © The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

                This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                : 23 June 2020
                : 04 July 2020
                : 07 July 2020
                : 23 July 2020
                Page count
                Pages: 7
                Funding
                Funded by: Boston Children’s Hospital Office of Faculty Development, Basic/Translational Executive Committee;
                Funded by: Clinical and Translational Research Executive Committee;
                Categories
                Case Report
                AcademicSubjects/MED00670
                AcademicSubjects/MED00290
                Custom metadata
                PAP
                corrected-proof

                covid-19,infant,neonatal sepsis,remdesivir,sars-cov-2
                covid-19, infant, neonatal sepsis, remdesivir, sars-cov-2

                Comments

                Comment on this article